Answer

Human Metapneumovirus (HMPV) has emerged as a global health concern, especially for vulnerable populations such as children, the elderly, and immunocompromised individuals. First identified in 2001, HMPV causes significant respiratory infections worldwide, leading to hospitalization and mortality, particularly in low-income countries. With viral outbreaks like HMPV posing increasing challenges, strengthening regulatory frameworks is crucial for effective management.

Enroll now for UPSC Online Course

Emergence of Human Metapneumovirus (HMPV) as a Global Health Concern

• Global Prevalence: HMPV has become a significant global health concern due to its widespread circulation, especially during seasonal outbreaks. The virus is gaining attention as its impact increases across regions.
  For example: In China, heightened surveillance has revealed a surge in HMPV cases, especially in children and the elderly, indicating increased detection rates.
• Emerging Pathogen: Although first identified in 2001, HMPV has gained attention due to rising respiratory infections worldwide, causing hospitalizations and deaths.
  For example: The World Health Organization reports that HMPV accounts for 3%-10% of hospital admissions globally, with a notable rise in children under five years.
• Seasonal Surge: The virus often spikes during the flu season, contributing to a rise in respiratory infections, making it a seasonal health threat.
  For example: In China, the flu season coincides with the spike in HMPV cases, leading to an increase in hospital admissions and media coverage.
• Insufficient Diagnostics: Despite being in circulation for years, many countries, including India, lack widespread and affordable testing infrastructure for HMPV.
• Global Monitoring Gaps: While global agencies monitor HMPV, its detection and reporting still face challenges in many regions, affecting early interventions.

The Virus Disproportionately Affects Certain Vulnerable Groups

• Children under Five: HMPV disproportionately affects young children, especially those under five years, who are at higher risk of severe illness and hospitalization.
• Elderly Populations: The elderly, particularly those with pre-existing health conditions, are more susceptible to severe outcomes from HMPV infections.
  For example: In China, the rise in HMPV cases among the elderly has led to hospitalizations, highlighting the vulnerability of older populations.
• Immunocompromised Individuals: People with weakened immune systems are at greater risk of severe infections from HMPV, requiring intensive medical care.
• Increased Fatality in Vulnerable Groups: Fatalities due to HMPV are notably higher in vulnerable groups, including infants and the immunocompromised.
  For example: The fatality rate for children under five is 1%, which raises concerns about the virus’s impact on high-risk populations in both developed and developing nations.
• Limited Access to Healthcare: In low- and middle-income countries, limited healthcare access exacerbates the risks of severe outcomes for vulnerable populations.

Measures To Strengthen Regulatory Framework And Capabilities To Manage Such Viral Outbreaks

• Strengthen Diagnostic Infrastructure: India can enhance its diagnostic capabilities by expanding testing facilities for viruses like HMPV across both government and private sectors.
  For instance: The Indian Council of Medical Research (ICMR) can collaborate with private labs to ensure widespread, affordable HMPV testing, allowing for early detection and containment.
• Accelerate Approval Processes: India can expedite the approval process for diagnostic tests by establishing a streamlined regulatory pathway that allows for faster approval of tests during public health emergencies.
  For instance: The Drug Controller General of India (DCGI) can implement emergency approval mechanisms for diagnostic kits that meet international standards.
• Develop National Surveillance System: A robust national surveillance system can be developed to monitor respiratory infections in real-time, tracking trends and emerging threats like HMPV.
  For example: The Ministry of Health and Family Welfare can expand the Integrated Disease Surveillance Programme (IDSP) to include real-time HMPV tracking across all states.
• Public Awareness Campaigns: India can initiate public health campaigns to increase awareness of HMPV, focusing on prevention methods and recognizing symptoms, particularly among vulnerable populations.
  For example: The Health Ministry can partner with media and NGOs to run information campaigns, particularly in rural areas, on recognizing symptoms of respiratory infections like HMPV.
• Strengthen International Collaboration: India can enhance its global collaboration to share information and resources for managing viral outbreaks, ensuring timely responses to emerging pathogens.

Check Out UPSC CSE Books From PW Store

India must enhance its regulatory framework to address emerging viral threats like HMPV by strengthening surveillance, diagnostics, and rapid response mechanisms through National Health Mission (NHM) initiatives. Investment in vaccine and antiviral research, alongside global best practices, will help mitigate such outbreaks. Strengthening healthcare infrastructure is essential to protect vulnerable populations and control HMPV spread.

DOWNLOAD PDF